This event is now fully booked, if you wish to go on the waiting list please email us.
The Royal College of Pathologists (RCPath) is hosting this new conference with the National Cancer Research Institute (NCRI) initiative, CM-Path (Cellular molecular pathology initiative). CM-Path aims to achieve the change needed to support academic cellular molecular pathology in the UK and make the resulting benefits available to the wider research community.
PROGRAMME
09.30 Registration and Coffee
10.00 Introduction and Welcome - Dr Karin Oien and Dr Alex Freeman
10.15 Strategic importance of Pathology in Clinical Trials: towards Precision Medicine? Dr Rowena Sharpe
10.35 Role of NCRI and Clinical Studies Groups - Ms Nicola Keat
10.55 Overview of potential pathology contribution to Clinical Trials – from inception to completion - Professor Gary Middleton and Dr Emily Shaw
11.45 Using tissue in Clinical Trials – rules and regulations, storage and access - Dr Bridget Wilkins
12.15 Lunch
13.05 Pathology-based testing of tissues in Clinical Trials – Performance, Standardisation and Quality Control - Professor Adrienne Flanagan
13.35 Issues in interpretation of pathology tests - Dr Max Robinson
14.05 Training - What should a Clinical Trial Pathologists know? - Professor Manuel Salto-Tellez
14.25 Funding opportunities for Clinical Trial Pathologists - Professor Ian Cree
14.45 Coffee Break
15.00 Break-out Groups:
Getting started in Clinical Trials as a Pathology Trainee or Consultant CM-Path Faculty
Clinical Trials in Practice – lessons learned CM-Path Faculty
16.00 Drinks and networking opportunity
16.30 Close